Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene



Título del documento: Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
Revista: Genetics and molecular biology
Base de datos: PERIÓDICA
Número de sistema: 000420004
ISSN: 1415-4757
Autores: 1
1
1
1
1
1
1
1
Instituciones: 1COMSATS Institute of Information Technology, Islamabad. Pakistán
Año:
Periodo: Sep
Volumen: 41
Número: 3
Paginación: 570-577
País: Brasil
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Analítico
Resumen en inglés Paraoxonase 1 (PON1) is a serum enzyme associated with high density lipoprotein (HDL) regulation through its paraoxonase and arylesterase activity. PON1 inhibits the oxidation of HDL and low density lipoprotein (LDL), and is involved in the pathogenesis of a variety of diseases including atherosclerosis. Conversely, mutations in the low den - sity lipoprotein receptor ( LDLR ) result in failure of receptor mediated endocytosis of LDL leading to its elevated plasma levels and onset of familial hypercholesterolemia (FH). In the current study we investigated the role of PON1 polymorphisms rs662; c.575A > G (p.Gln192Arg) and rs854560; c.163T > A (p.Leu55Met) in a large family having FH patients harboring a functional mutation in LDLR. Genotypes were revealed by RFLP, followed by confirmation through Sanger sequencing. PON1 activity was measure by spectrophotometry. Our results show significantly reduced serum paraoxonase and arylesterase activities in FH patients compared with the healthy individuals of the family (p < 0.05). PON1 QQ192 genotype showed a significantly higher association with FH (p=0.0002). PON1 Q192 isoform was associated with reduced serum paraoxonase activity by in silico analysis and PON1 R192 exhibited higher serum paraoxonase and arylesterase activity than the other polymorphs. Our results highlight that the combination of LDLR mutations and PON1 MMQQ genotypes may lead to severe cardiac events
Disciplinas: Química,
Medicina
Palabras clave: Bioquímica,
Endocrinología,
Sistema cardiovascular,
Paraoxonasa-1,
Hipercolesterolemia,
Arilesterasa,
Mutaciones,
Gen LDLR
Keyword: Biochemistry,
Endocrinology,
Cardiovascular system,
Paraoxonase-1,
Hypercholesteremia,
Arylesterase,
Mutations,
LDLR gene
Texto completo: Texto completo (Ver PDF)